Departamento Microbiología e Inmunología, Universidad Nacional de Río Cuarto, 5800 Río Cuarto, Córdoba, Argentina.
Curr Microbiol. 2012 Apr;64(4):349-56. doi: 10.1007/s00284-011-0077-0. Epub 2012 Jan 10.
Group B streptococci (GBS) are bacterial species that colonize the vagina in pregnant women and as such may cause serious infections in neonates that passed through the birth channel. The objective of this work was to study the inhibitory activities produced by each bacteriocin-like inhibitory substance (BLIS) of Lactobacillus rhamnosus L60 and Lactobacillus fermentum L23, and the effects of the combined BLIS-es of these lactobacilli on GBS. The interactions between the BLIS-es were assessed by qualitative and quantitative methods on agar plates. The minimum inhibitory concentrations (MICs) and fractional inhibitory concentrations (FICs) were determined by a modification of the broth microdilution and checkerboard methods, respectively. Antibiotic susceptibilities of all S. agalactiae strains were assayed and the results of these tests were evaluated for statistical significance. A 7.5% of GBS isolates were recovered from 760 pregnant women and 91% of those strains were susceptible to each BLIS produced by L. fermentum, L. rhamnosus, and also to a mixture of them. The comparisons among the BLIS-es showed statistically significant differences, with a combination of the BLIS-es from the two Lactobacillus species being better than the BLIS of each one alone (P < 0.05) as GBS growth inhibitors. Synergistic activities between the BLIS-es were found on 100% of susceptible GBS strains, MICs ranges of BLIS of L23 and L60 were 80-160 and 160-320 UA ml(-1), respectively. By the checkerboard method, the BLIS-es combination showed synergistic effect on all sensitive strains tested, with values of FICs ranging from 0.131 to 0.218. The BLIS-es produced by these lactobacilli of vaginal origin were able to inhibit S. agalactiae isolates. The results indicate that these strains may have probiotic potential for the control of GBS in women and may consequently prevent GBS infections in newborns.
B 群链球菌(GBS)是一种定植于孕妇阴道的细菌,可导致经产道娩出的新生儿发生严重感染。本研究的目的是研究罗伊氏乳杆菌 L60 和发酵乳杆菌 L23 所产生的每一种细菌素抑制物(BLIS)的抑制活性,以及这两种乳酸菌的 BLIS 混合物对 GBS 的影响。通过琼脂平板的定性和定量方法评估 BLIS 之间的相互作用。通过肉汤微量稀释和棋盘微量稀释法的改良,分别测定最小抑菌浓度(MIC)和部分抑菌浓度(FIC)。对所有无乳链球菌菌株进行抗生素药敏试验,并对这些试验结果进行统计学意义评估。从 760 名孕妇中分离出 7.5%的 GBS 分离株,其中 91%的菌株对发酵乳杆菌、罗伊氏乳杆菌产生的每一种 BLIS 以及它们的混合物均敏感。BLIS 之间的比较显示出统计学上的显著差异,两种乳酸菌的 BLIS 混合物的效果优于单一 BLIS(P<0.05),作为 GBS 生长抑制剂。在 100%的敏感 GBS 菌株上发现 BLIS 之间存在协同作用,L23 和 L60 的 BLIS 最低抑菌浓度(MIC)范围分别为 80-160 和 160-320 UA ml(-1)。棋盘微量稀释法显示,BLIS 混合物对所有敏感菌株均表现出协同作用,FIC 值范围为 0.131-0.218。这些阴道来源的乳酸菌产生的 BLIS 能够抑制无乳链球菌分离株。结果表明,这些菌株可能具有控制女性 GBS 的益生菌潜力,并可预防新生儿 GBS 感染。